Cleared Traditional

K823088 - ASPITRON

K823088 is an FDA 510(k) clearance for ASPITRON, manufactured by Intl. Ophthalmic Industries Corp.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 169-day FDA review.

K823088 · Intl. Ophthalmic Industries Corp. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1983
Decision
169d
Days
Class 2
Risk

K823088 is an FDA 510(k) clearance for the ASPITRON. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Intl. Ophthalmic Industries Corp. (Mchenry, US). The FDA issued a Cleared decision on April 6, 1983 after a review of 169 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Intl. Ophthalmic Industries Corp. devices

FDA 510(k) Submission Details - K823088

510(k) Number K823088 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 19, 1982
Decision Date April 06, 1983
Days to Decision 169 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
59d slower than avg
Panel avg: 110d · This submission: 169d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.